Veronika Wirtz, PhD, MSc
Associate Professor
Boston University School of Public Health
Dept of Global Health

PhD, University of London
MSc, University of London

Veronika J. Wirtz, MSc, PhD is an Associate Professor in the Department of Global Health at the Boston University School of Public Health, where she is also Director of the World Health Organization Collaborating Center in Pharmaceutical Policy and Director of the Certificate in Pharmaceutical Development, Delivery and Access. Her research focuses on health system strengthening and policy and program evaluations of medicines access and utilization. She is a Visiting Professor of the National Institute of Public Health (INSP) in Mexico and coordinator of a student exchange program between the institutions of her affiliation.

Her interest and expertise include medicines price analysis, generic medicines policies, quality use of medicines, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance.

Between 2014 and 2016 she was the Co-Chair of The Lancet Commission on Essential Medicine Policies. The Commission had the goals of (1) re-confirming the ongoing relevance, and the crucial need of comprehensive essential medicines policies to achieve broader global health and sustainable development goals, especially universal health coverage and (2) formulating recommendations for global essential medicine policies for the next two decades. The Report of the Commission Essential Medicines for Universal Coverage was published in 2016.

From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health (INSP) in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. Over the last years she has regularly taught short courses in Pharmacoepidemiology and Medicines Utilization Research at INSP in Mexico.

She has worked as a technical adviser for various international organizations, among them the World Health Organization, the Pan American Health Organization, the World Bank, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Alliance for Health Systems and Policy Research, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health. Since Fall 2016 she is Associate Editor of Health Systems & Reform, a leading journal publishing health system and policy research.

She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.

2019 International Society in Pharmacoepidemiology and Drug Safety (ISPE): Fellow
2017-2019 International Society in Pharmacoepidemiology and Drug Safety (ISPE): Chair, Special Interest Group in Drug Utilization
2015 Boston University School of Public Health: Boston University School of Public Health: Excellence in Teaching Award
2014-2016 The Lancet Commission on Essential Medicines Policies: Co-Chair
2009-2014 National System of Researchers (SNI), National Council for Science and Technology, Mexico : Member
2009-2010 Coordinating Commission of the National Institutes of Health and Tertiary Hospitals, Mexico: Excellence in Research Productivity
2007 Research Conference of the National Institutes of Health and Tertiary Hospitals, Mexico: Nominee for Best Research Presentation
2007-2009 National System of Researchers (SNI), National Council for Science and Technology, Mexico: Awarded Membership as Candidate
1999-2003 School of Pharmacy, University of London: PhD Studies Scholarship

Novartis Access Initiative Task Order 4
11/01/2017 - 10/31/2019 (Co-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH

Evaluation of Novartis Access in Kenya - Scope of Work 5
01/01/2019 - 09/30/2019 (Co-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH

Factors influencing the uptake of the tenofovir voluntary licensing program by eligible manufacturers and medicine purchasers in licensed countries
01/01/2019 - 09/30/2019 (PI)
Gilead Sciences, Inc.

Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program
11/05/2018 - 02/28/2019 (PI)
Management Sciences for Health USAID

Country profiles of health technologies including medicines in the Americas: A pilot study
09/21/2018 - 12/28/2018 (PI)
Pan American Health Organization

Country collaborations on medicines: identifying opportunities to improve performance (Phase 1)
05/15/2018 - 06/10/2018 (PI)
World Health Organization

Novartis Access Initiative Task Order 3
10/01/2016 - 04/30/2018 (Co-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH

Novartis Access Initiative Task Order 2
04/29/2016 - 02/28/2018 (Co-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH

10/01/2015 - 02/28/2018 (PI)
Management Sciences for Health USAID

Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) Study
03/17/2017 - 08/31/2017 (PI)
Health Action International Leona&Harry Helmsley

Showing 10 of 13 results. Show All Results

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kaplan WA, Cárdenas J, Mansilla C, Tobar T, Wirtz VJ. The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data. PLoS One. 2019; 14(5):e0217334.View Related Profiles. PMID: 31141565.
  2. Beran D, Laing RO, Kaplan W, Knox R, Sharma A, Wirtz VJ, Frye J, Ewen M. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices. Diabet Med. 2019 Jun; 36(6):726-733.View Related Profiles. PMID: 30888075.
  3. Mansilla C, Cárdenas J, Kaplan WA, Wirtz VJ, Kuhn-Barrientos L, Ortíz de Zárate M, Tobar T, Herrera CA. Evaluation of the effects of a generic substitution policy implemented in Chile. BMJ Glob Health. 2017; 2(Suppl 3):e000922.View Related Profiles. PMID: 30899555.
  4. Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in low- and middle-income countries: a systematic review. BMJ Glob Health. 2019; 4(1):e001258. PMID: 30899566.
  5. Rockers PC, Laing RO, Ashigbie PG, Onyango MA, Mukiira CK, Wirtz VJ. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2019 Apr; 7(4):e492-e502.View Related Profiles. PMID: 30799142.
  6. Simão M, Wirtz VJ, Al-Ansary LA, Hill S, Grove J, Gray AL, Nannei C, Hedman L, Das P, Hogerzeil H. A global accountability mechanism for access to essential medicines. Lancet. 2018 12 08; 392(10163):2418-2420. PMID: 30527401.
  7. Syed N, Rockers PC, Vian T, Onyango M, Laing RO, Wirtz VJ. Access to Antihypertensive Medicines at the Household Level: A Study From 8 Counties of Kenya. Glob Heart. 2018 12; 13(4):247-253.e5.View Related Profiles. PMID: 30245176.
  8. Onyango MA, Vian T, Hirsch I, Salvi DD, Laing R, Rockers PC, Ashigbie PG, Wirtz VJ. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study. PLoS One. 2018; 13(8):e0201917.View Related Profiles. PMID: 30142218.
  9. Rockers PC, Reich MR, Kettler H, Wirtz VJ. Commitment to Impact: Strengthening Measurement of Industry-Led Access-to-Medicines Programs. Health Syst Reform. 2018; 4(3):188-193.View Related Profiles. PMID: 30060703.
  10. Mehrtash H, Laing R, Wirtz VJ. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region. East Mediterr Health J. 2018 Jul 17; 24(5):427-434.View Related Profiles. PMID: 30043961.
Showing 10 of 115 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 115 publications over 18 distinct years, with a maximum of 15 publications in 2013

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Health Systems Research
Pharmaceutical Policy Research
Drug Utilization
Low Income Populations
Latin America
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Wirtz's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department